← Leaderboards
Adithya Cattamanchi
University Of California, San Francisco
$24,815,234
Attributed
$53,769,308
Total exposure
13
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $9.7M · FY2009–25$10M$7.5M$5M$2.5M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$53,769,308 · 13
By mechanism
R01$28,957,949 · 8
U01$19,349,651 · 1
K12$2,907,100 · 1
T32$1,416,603 · 1
K23$760,391 · 1
R21$377,614 · 1
Top collaborators
- Claudia Maria Denkinger14 shared
- Payam Nahid14 shared
- Joel D. Ernst12 shared
- David Wesley Dowdy8 shared
- Kirsten Bibbins-Domingo5 shared
- Midori Kato-Maeda5 shared
- Swomitra K Mohanty3 shared
- Fred C Semitala3 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Lyudmila Popova$5,221,407
- Pamela May Ling$21,183,506
- Michael R Wilson$8,552,789
- Janice Y. Tsoh$9,696,129
- Gideon St.helen$5,881,549
Others in their field
Top investigators on “Tuberculosis”
- Judith S. Currier · University Of California Los Angeles$301,722,065
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$297,204,160
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$267,912,117
- Lawrence Corey · Fred Hutchinson Cancer Center$255,939,398
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$200,192,298
- Sharon A Nachman · Johns Hopkins University$194,852,226
Research focus
TuberculosisEvaluationCountryDiagnosisPerformanceDiagnosticMortalityUgandaFundingCostProgramsDiagnostic AccuracyWorld Health OrganizationSamplingSitePharmaceutical PreparationsNext GenerationCaringCharacteristicsHealth SystemDesignEpidemiologyFailureDiagnostic Tests
Grant awards (63)
Rapid Research for Diagnostics Development in TB Network: Episode 2 (R2D2 TB Network II)$2,408,741
R01 · FY2025 · AI
PROgression of Tuberculosis infECTion in young children living with and without HIV: the PROTECT study$1,061,038
R01 · FY2025 · AI · contact PI
Diagnosis of tuberculosis and monitoring of treatment via RNA liquid biopsy$743,651
R01 · FY2025 · AI
Rapid Research for Diagnostics Development in TB Network: Episode 2 (R2D2 TB Network II)$648,576
R01 · FY2025 · AI
Partnerships for Research in Implementation Science for Equity in Heart and Lung diseases training program (PRISE-HL T32)$465,458
T32 · FY2025 · HL
Rapid Research for Diagnostics Development in TB Network: Episode 2 (R2D2 TB Network II)$455,914
R01 · FY2025 · AI
Rapid Research for Diagnostics Development in TB Network: Episode 2 (R2D2 TB Network II)$433,790
R01 · FY2025 · AI
Options for Delivery of Short-Course Tuberculosis Preventive Therapy: The 3HP Options Trial$427,901
R01 · FY2025 · HL · contact PI
Rapid Research for Diagnostics Development in TB Network: Episode 2 (R2D2 TB Network II)$323,255
R01 · FY2025 · AI
Rapid Research for Diagnostics Development in TB Network: Episode 2 (R2D2 TB Network II)$225,051
R01 · FY2025 · AI
Rapid Research for Diagnostics Development in TB Network: Episode 2 (R2D2 TB Network II)$216,001
R01 · FY2025 · AI
Options for Delivery of Short-Course Tuberculosis Preventive Therapy: The 3HP Options Trial$144,978
R01 · FY2025 · HL · contact PI
Options for Delivery of Short-Course Tuberculosis Preventive Therapy: The 3HP Options Trial$69,299
R01 · FY2025 · HL · contact PI
Rapid Research for Diagnostics Development in TB Network: Episode 2 (R2D2 TB Network II)$49,256
R01 · FY2025 · AI
PROgression of Tuberculosis infECTion in young children living with and without HIV: the PROTECT study$41,814
R01 · FY2025 · AI · contact PI
PROgression of Tuberculosis infECTion in young children living with and without HIV: the PROTECT study$1,831
R01 · FY2025 · AI · contact PI
Rapid Research for Diagnostics Development in TB Network (R2D2 TB Network)$3,929,838
U01 · FY2024 · AI
C3PO - The Candidate Clinical Correlate of Prognostic Outcome for TB Study$2,655,299
U01 · FY2024 · AI
Childhood âOmicsâ and Mycobacterium tuberculosis-derived BiOsignatures (COMBO) for TB diagnosis in high HIV prevalence settings$1,278,151
R01 · FY2024 · AI · contact PI
PROgression of Tuberculosis infECTion in young children living with and without HIV: the PROTECT study$1,025,117
R01 · FY2024 · AI · contact PI
Partnerships for Research in Implementation Science for Equity in Heart and Lung diseases training program (PRISE-HL T32)$482,508
T32 · FY2024 · HL
Childhood Omics and Mycobacterium tuberculosis-derived BiOsignatures (COMBO) for TB diagnosis in high HIV prevalence settings$347,159
R01 · FY2024 · AI · contact PI
Childhood âOmicsâ and Mycobacterium tuberculosis-derived BiOsignatures (COMBO) for TB diagnosis in high HIV prevalence settings$1,410,811
R01 · FY2023 · AI · contact PI
PROgression of Tuberculosis infECTion in young children living with and without HIV: the PROTECT study$1,105,532
R01 · FY2023 · AI · contact PI
Rapid Research for Diagnostics Development in TB Network (R2D2 TB Network)$1,016,488
U01 · FY2023 · AI
Partnerships for Research in Implementation Science for Equity in Heart and Lung diseases training program (PRISE-HL T32)$468,637
T32 · FY2023 · HL
Rapid Research for Diagnostics Development in TB Network (R2D2 TB Network)$3,977,411
U01 · FY2022 · AI
Childhood âOmicsâ and Mycobacterium tuberculosis-derived BiOsignatures (COMBO) for TB diagnosis in high HIV prevalence settings$1,039,959
R01 · FY2022 · AI · contact PI
Options for Delivery of Short-Course Tuberculosis Preventive Therapy: The 3HP Options Trial$594,179
R01 · FY2022 · HL · contact PI
Childhood âOmicsâ and Mycobacterium tuberculosis-derived BiOsignatures (COMBO) for TB diagnosis in high HIV prevalence settings$518,294
R01 · FY2022 · AI · contact PI
Rapid Research for Diagnostics Development in TB Network (R2D2 TB Network)$3,996,362
U01 · FY2021 · AI · contact PI
Childhood âOmicsâ and Mycobacterium tuberculosis-derived BiOsignatures (COMBO) for TB diagnosis in high HIV prevalence settings$1,490,544
R01 · FY2021 · AI · contact PI
Options for Delivery of Short-Course Tuberculosis Preventive Therapy: The 3HP Options Trial$597,392
R01 · FY2021 · HL · contact PI
UCSF Career Development Program in Implementation Research in Heart and Lung Diseases$408,726
K12 · FY2021 · HL · contact PI
Rapid Research for Diagnostics Development in TB Network (R2D2 TB Network)$3,774,253
U01 · FY2020 · AI · contact PI
Childhood âOmicsâ and Mycobacterium tuberculosis-derived BiOsignatures (COMBO) for TB diagnosis in high HIV prevalence settings$1,503,586
R01 · FY2020 · AI · contact PI
UCSF Career Development Program in Implementation Research in Heart and Lung Diseases$945,765
K12 · FY2020 · HL
Improving the molecular diagnosis of drug resistant tuberculosis$696,601
R01 · FY2020 · AI
Evaluation of a novel breath sensor for rapid, low-cost diagnosis of tuberculosis in children$655,395
R01 · FY2020 · HL · contact PI
SIngle-saMPLE tuberculosis evaluation to facilitate linkage to care: The SIMPLE TB trial$622,459
R01 · FY2020 · HL · contact PI
Options for Delivery of Short-Course Tuberculosis Preventive Therapy: The 3HP Options Trial$607,486
R01 · FY2020 · HL · contact PI
UCSF Career Development Program in Implementation Research in Heart and Lung Diseases$955,485
K12 · FY2019 · HL
Improving the molecular diagnosis of drug resistant tuberculosis$742,543
R01 · FY2019 · AI
Evaluation of a novel breath sensor for rapid, low-cost diagnosis of tuberculosis in children$679,804
R01 · FY2019 · HL · contact PI
SIngle-saMPLE tuberculosis evaluation to facilitate linkage to care: The SIMPLE TB trial$627,536
R01 · FY2019 · HL · contact PI
Options for Delivery of Short-Course Tuberculosis Preventive Therapy: The 3HP Options Trial$614,073
R01 · FY2019 · HL · contact PI
Options for Delivery of Short-Course Tuberculosis Preventive Therapy: The 3HP Options Trial$725,916
R01 · FY2018 · HL · contact PI
Evaluation of a novel breath sensor for rapid, low-cost diagnosis of tuberculosis in children$715,508
R01 · FY2018 · HL · contact PI
Improving the molecular diagnosis of drug resistant tuberculosis$696,346
R01 · FY2018 · AI
SIngle-saMPLE tuberculosis evaluation to facilitate linkage to care: The SIMPLE TB trial$630,464
R01 · FY2018 · HL · contact PI
UCSF Career Development Program in Implementation Research in Heart and Lung Diseases$510,297
K12 · FY2018 · HL
Improving the molecular diagnosis of drug resistant tuberculosis$709,614
R01 · FY2017 · AI
SIngle-saMPLE tuberculosis evaluation to facilitate linkage to care: The SIMPLE TB trial$641,495
R01 · FY2017 · HL · contact PI
UCSF Career Development Program in Implementation Research in Heart and Lung Diseases$86,827
K12 · FY2017 · HL
Improving the molecular diagnosis of drug resistant tuberculosis$731,000
R01 · FY2016 · AI
SIngle-saMPLE tuberculosis evaluation to facilitate linkage to care: The SIMPLE TB trial$699,889
R01 · FY2016 · HL · contact PI
Immunodiagnosis of Active Tuberculosis in HIV-infected Patients$152,446
K23 · FY2013 · HL · contact PI
TB Guidline Observation and Adherence in Low Income Countries (TB GOAL)$201,377
R21 · FY2012 · AI · contact PI
Immunodiagnosis of Active Tuberculosis in HIV-infected Patients$152,446
K23 · FY2012 · HL · contact PI
TB Guidline Observation and Adherence in Low Income Countries (TB GOAL)$176,237
R21 · FY2011 · AI · contact PI
Immunodiagnosis of Active Tuberculosis in HIV-infected Patients$152,446
K23 · FY2011 · HL · contact PI
Immunodiagnosis of Active Tuberculosis in HIV-infected Patients$151,643
K23 · FY2010 · HL · contact PI
Immunodiagnosis of Active Tuberculosis in HIV-infected Patients$151,410
K23 · FY2009 · HL · contact PI